Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,039 USD | -0.60% |
|
+1.11% | +18.31% |
06-18 | Alvotech Enters Commercialization Deal for Eylea Biosimilars with Advanz Pharma | MT |
06-17 | Regeneron Pharmaceuticals Insider Sold Shares Worth $1,596,400, According to a Recent SEC Filing | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.31% | 112B | |
+14.84% | 121B | |
+4.48% | 22.57B | |
-18.26% | 20.82B | |
-16.75% | 16.19B | |
-42.36% | 16.17B | |
-14.23% | 16.3B | |
-0.68% | 13.17B | |
+21.87% | 11.11B | |
+111.62% | 10.57B |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.
- Transcript : Regeneron Pharmaceuticals, Inc. Presents at Barclays Global Healthcare Conference, Mar-15-2023 09